Screening of KCNN3 in patients with early-onset lone atrial fibrillation

Europace

Volumn 13, Issue 7, 2011, Pages 963-967

  Olesen, Morten S ^a,b,c   Jabbari, Javad ^a,b,c   Holst, Anders G ^a,b,c   Nielsen, Jonas B ^a,b,c   Steinbrüchel, Daniel A ^a   Jespersen, Thomas ^a   Haunsø, Stig ^a,b,c   Svendsen, Jesper H ^a,b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Genetics; KCNN3; Lone atrial fibrillation; Potassium intermediate small conductance calcium activated channel; Single nucleotide polymorphism; SK3

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL;

ADULT; ARTICLE; BLOOD DONOR; CARDIAC PATIENT; CONTROLLED STUDY; DENMARK; ELECTROCARDIOGRAM; ETHNICITY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART ATRIUM FIBRILLATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; KCNN3 GENE; LONE ATRIAL FIBRILLATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; COHORT STUDIES; DENMARK; ELECTROCARDIOGRAPHY; EXONS; FEMALE; GENETIC TESTING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS;

EID: 79959692889     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur007     Document Type: Article

References (38)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
2. Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHC et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53.
3. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 2004;110:1042-6. (Pubitemid 39319000)
4. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-26. (Pubitemid 34059528)
5. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/ AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:700-52. (Pubitemid 44252312)
6. Fox CS, Parise H, D'Agostino RB, Lloyd-Jones DM, Vasan RS, Wang TJ et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004;291:2851-5. (Pubitemid 38747806)
7. Christophersen IE, Ravn LS, Budtz-Joergensen E, Skytthe A, Haunsoe S, Svendsen JH et al. Familial aggregation of atrial fibrillation: a study in Danish twins. Circ Arrhythm Electrophysiol 2009;2:378-83.
8. Lubitz SA, Yi BA, Ellinor PT. Genetics of atrial fibrillation. Cardiol. Clin. 2009;27:25-33.
9. Lundby A, Ravn LS, Svendsen JH, Haunsø S, Olesen S, Schmitt N. KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol Biochem 2008;21:047-054.
10. Yang Y, Li J, Lin X, Yang Y, Hong K, Wang L et al. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet 2009;54:277-83.
11. Chen Y, Xu S, Bendahhou S, Wang X, Wang Y, Xu W et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-4. (Pubitemid 36125211)
12. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004;75:899-905. (Pubitemid 39390498)
13. Andalib A, Brugada R, Nattel S. Atrial fibrillation: evidence for genetically determined disease. Curr Opin Cardiol 2008;23:176-83. (Pubitemid 351489319)
14. Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 2008;52:1326-34.
15. Lundby A, Ravn LS, Svendsen JH, Olesen S, Schmitt N. KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm 2007;4:1532-41. (Pubitemid 350187683)
16. Watanabe H, Darbar D, Kaiser DW, Jiramongkolchai K, Chopra S, Donahue BS et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2009;2:268-75.
17. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353-7. (Pubitemid 47080348)
18. Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009;41:879-81.
19. Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV et al. Genome-wide association study of PR interval. Nat Genet 2010;42:153-9.
20. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010;42:240-4.
21. Soltysinska E, Olesen S, Christ T, Wettwer E, Varró A, Grunnet M et al. Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts. Pflugers Arch 2009;459:11-23.
22. Calloe K, Soltysinska E, Jespersen T, Lundby A, Antzelevitch C, Olesen S et al. Differential effects of the transient outward K(+) current activator NS5806 in the canine left ventricle. J Mol Cell Cardiol 2010;48:191-200.
23. Lai L, Su M, Yeh H, Lin J, Chiang F, Hwang J et al. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 2002;144:485-90.
24. Watanabe H, Darbar D, Kaiser DW, Jiramongkolchai K, Chopra S, Donahue BS et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2009:2:268-75.
25. Boldt L, Posch MG, Perrot A, Polotzki M, Rolf S, Parwani AS et al. Mutational analysis of the PITX2 and NKX2-5 genes in patients with idiopathic atrial fibrillation. Int J Cardiol 2010:145:316-7.
26. Pfeufer A, Sanna S, Arking DE, Muller M, Gateva V, Fuchsberger C et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 2009;41:407-14.
27. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PIW, Yin X, Estrada K et al. Common variants at ten loci influence QT interval duration in the QTGEN study. Nat Genet 2009;41:399-406.
28. Tuteja D, Rafizadeh S, Timofeyev V, Wang S, Zhang Z, Li N et al. Cardiac small conductance Ca2+-activated K+ channel subunits form heteromultimers via the coiled-coil domains in the C termini of the channels. Circ Res 2010;107:851-9.
29. Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them? Methods Mol Biol 2009;578:23-39.
30. Goymer P. Synonymous mutations break their silence. Nat Rev Genet 2007;8:92.
31. Chamary JV, Parmley JL, Hurst LD. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat Rev Genet 2006;7:98-108. (Pubitemid 43128905)
32. Purvis IJ, Bettany AJE, Santiago TC, Coggins JR, Duncan K, Eason R et al. The efficiency of folding of some proteins is increased by controlled rates of translation in vivo: a hypothesis. J Mol Biol 1987;193:413-7.
33. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006;314:1930-3. (Pubitemid 46026115)
34. Ivanov IG, Saraffova AA, Abouhaidar MG. Unusual effect of clusters of rare arginine (AGG) codons on the expression of human interferon [alpha]1 gene in Escherichia Coli. Int J Biochem Cell Biol 1997;29:659-66. (Pubitemid 27243994)
35. Parmley JL, Hurst LD. How do synonymous mutations affect fitness? BioEssays 2007;29:515-9.
36. Tsai C, Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM, Nussinov R. Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J Mol Biol 2008;383:281-91.
37. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res 2007;67:9609-12. (Pubitemid 47621204)
38. Xu Y, Tuteja D, Zhang Z, Xu D, Zhang Y, Rodriguez J et al. Molecular identification and functional roles of a Ca(2+)-activated K+ channel in human and mouse hearts. J Biol Chem 2003;278:49085-94.